Cargando…
Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry
BACKGROUND: Colon cancer (CC) is a disease of elderly patients (pts.) with a median age of 73 years (yrs.). Lack of data about the effects of adjuvant chemotherapy (ACT) is caused by underrepresentation of this clinically relevant cohort in interventional trials. We analyzed real‐world data from the...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041084/ https://www.ncbi.nlm.nih.gov/pubmed/35146948 http://dx.doi.org/10.1002/cam4.4540 |
_version_ | 1784694469730238464 |
---|---|
author | Nöpel‐Dünnebacke, Stefanie Jütte, Hendrick Denz, Robin Feder, Inke Sabine Kraeft, Anna‐Lena Lugnier, Celine Teschendorf, Christian Collette, Daniela Böhner, Hinrich Engel, Lars Mueller, Lothar Hartmann, Frank Kaiser, Ulrich Bruch, Harald‐Robert Hollerbach, Stephan Arnold, Dirk Timmesfeld, Nina Tannapfel, Andrea Reinacher‐Schick, Anke |
author_facet | Nöpel‐Dünnebacke, Stefanie Jütte, Hendrick Denz, Robin Feder, Inke Sabine Kraeft, Anna‐Lena Lugnier, Celine Teschendorf, Christian Collette, Daniela Böhner, Hinrich Engel, Lars Mueller, Lothar Hartmann, Frank Kaiser, Ulrich Bruch, Harald‐Robert Hollerbach, Stephan Arnold, Dirk Timmesfeld, Nina Tannapfel, Andrea Reinacher‐Schick, Anke |
author_sort | Nöpel‐Dünnebacke, Stefanie |
collection | PubMed |
description | BACKGROUND: Colon cancer (CC) is a disease of elderly patients (pts.) with a median age of 73 years (yrs.). Lack of data about the effects of adjuvant chemotherapy (ACT) is caused by underrepresentation of this clinically relevant cohort in interventional trials. We analyzed real‐world data from the German CPP registry with regard to a possible benefit of ACT in elderly (70+ yrs.) versus younger pts. (50 to <70 yrs.) taking cause‐specific deaths into account. METHODS: We analyzed the effect of age and ACT on overall survival (OS) and cause‐specific death of stage III pts. using Cox regression. RESULTS: In total, 1558 pts. were analyzed and follow‐up was 24.6 months. 62.6% of the elderly received ACT whereas 91.1% of younger pts. (p < 0.001). Oxaliplatin combinations were significantly less often given to older than younger pts. (38.8% vs. 88.9%; p < 0.001). Mean Charlson comorbidity score was significantly lower in pts. that received ACT (0.61) than in those without ACT (1.16; p < 0.001). ACT was an independent positive prognostic factor for cancer‐related death in elderly pts. even in pts. 75+ yrs. No significant difference in the effect of ACT could be observed between age groups (interaction: cancer‐specific death HR = 1.7948, p = 0.1079; death of other cause HR = 0.7384, p = 0.6705). CONCLUSION: ACT was an independent positive prognostic factor for OS. There may be a cohort of elderly with less co‐morbidities who benefit from ACT. |
format | Online Article Text |
id | pubmed-9041084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90410842022-04-28 Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry Nöpel‐Dünnebacke, Stefanie Jütte, Hendrick Denz, Robin Feder, Inke Sabine Kraeft, Anna‐Lena Lugnier, Celine Teschendorf, Christian Collette, Daniela Böhner, Hinrich Engel, Lars Mueller, Lothar Hartmann, Frank Kaiser, Ulrich Bruch, Harald‐Robert Hollerbach, Stephan Arnold, Dirk Timmesfeld, Nina Tannapfel, Andrea Reinacher‐Schick, Anke Cancer Med Clinical Cancer Research BACKGROUND: Colon cancer (CC) is a disease of elderly patients (pts.) with a median age of 73 years (yrs.). Lack of data about the effects of adjuvant chemotherapy (ACT) is caused by underrepresentation of this clinically relevant cohort in interventional trials. We analyzed real‐world data from the German CPP registry with regard to a possible benefit of ACT in elderly (70+ yrs.) versus younger pts. (50 to <70 yrs.) taking cause‐specific deaths into account. METHODS: We analyzed the effect of age and ACT on overall survival (OS) and cause‐specific death of stage III pts. using Cox regression. RESULTS: In total, 1558 pts. were analyzed and follow‐up was 24.6 months. 62.6% of the elderly received ACT whereas 91.1% of younger pts. (p < 0.001). Oxaliplatin combinations were significantly less often given to older than younger pts. (38.8% vs. 88.9%; p < 0.001). Mean Charlson comorbidity score was significantly lower in pts. that received ACT (0.61) than in those without ACT (1.16; p < 0.001). ACT was an independent positive prognostic factor for cancer‐related death in elderly pts. even in pts. 75+ yrs. No significant difference in the effect of ACT could be observed between age groups (interaction: cancer‐specific death HR = 1.7948, p = 0.1079; death of other cause HR = 0.7384, p = 0.6705). CONCLUSION: ACT was an independent positive prognostic factor for OS. There may be a cohort of elderly with less co‐morbidities who benefit from ACT. John Wiley and Sons Inc. 2022-02-11 /pmc/articles/PMC9041084/ /pubmed/35146948 http://dx.doi.org/10.1002/cam4.4540 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Nöpel‐Dünnebacke, Stefanie Jütte, Hendrick Denz, Robin Feder, Inke Sabine Kraeft, Anna‐Lena Lugnier, Celine Teschendorf, Christian Collette, Daniela Böhner, Hinrich Engel, Lars Mueller, Lothar Hartmann, Frank Kaiser, Ulrich Bruch, Harald‐Robert Hollerbach, Stephan Arnold, Dirk Timmesfeld, Nina Tannapfel, Andrea Reinacher‐Schick, Anke Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry |
title | Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry |
title_full | Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry |
title_fullStr | Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry |
title_full_unstemmed | Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry |
title_short | Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry |
title_sort | causes of mortality in elderly uicc stage iii colon cancer (cc) patients––tumor‐related death and competing risks from the german aio colorectal study group colopredict plus (cpp) registry |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041084/ https://www.ncbi.nlm.nih.gov/pubmed/35146948 http://dx.doi.org/10.1002/cam4.4540 |
work_keys_str_mv | AT nopeldunnebackestefanie causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT juttehendrick causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT denzrobin causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT federinkesabine causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT kraeftannalena causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT lugnierceline causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT teschendorfchristian causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT collettedaniela causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT bohnerhinrich causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT engellars causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT muellerlothar causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT hartmannfrank causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT kaiserulrich causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT bruchharaldrobert causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT hollerbachstephan causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT arnolddirk causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT timmesfeldnina causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT tannapfelandrea causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry AT reinacherschickanke causesofmortalityinelderlyuiccstageiiicoloncancerccpatientstumorrelateddeathandcompetingrisksfromthegermanaiocolorectalstudygroupcolopredictpluscppregistry |